Immune surveillance of tumors
Jeremy B. Swann(Max Planck Institute of Immunobiology and Epigenetics), Mark J. Smyth(Peter MacCallum Cancer Centre)
Cited by 1,434
Related Papers
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
|Annals of Oncology|2014|1.3k
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
|Nature Immunology|2017|639